ArticleJournal of immunology (Baltimore, Md. : 1950)2014
Rituximab efficiently depletes increased CD20-expressing T cells in multiple sclerosis patients.
Arumugam Palanichamy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
150 papers cite itlatest 60 shown
this paperpooled ittrialcites it